HOME >> BIOLOGY >> NEWS
Yale immunologist studying host responses to infection named 2005 Searle Scholar

New Haven, Conn. -- John D. MacMicking, an assistant professor recently recruited to the Section of Microbial Pathogenesis at Yale School of Medicine, has been named as a 2005 Searle Scholar and will receive $240,000 during the next three years to support his research program on novel host defense pathways to infection.

MacMicking studies aspects of the interferon pathway that bridge the processes of innate and acquired immunity which are crucial for controlling infection of macrophages and dendritic cells by Mycobacterium tuberculosis (Mtb), the causative agent of TB.

MacMicking's selection was based on his demonstrated innovative research that has the potential for making significant and extended contributions to the complex innate immune response of higher organisms.

"Currently our research focuses on group of newly identified host proteins called Immune-related GTPases that are elicited in response to infection. These GTPases appear critical for preventing the pathogen from establishing a safe and nutrient-rich niche used for microbial growth," said MacMicking "The details of how these new proteins remodel the intracellular environment are still being worked out -- it's a fascinating challenge."

His research uses a combination of mammalian and mycobacterial genetics along with cell biology, immunology and protein crystallography to study these processes. It should lead to a better understanding of the biological relationship between eukaryote and prokaryote while providing a basis for rational TB vaccine or drug design in the future.

"What makes the Searle award so special is that it gives investigators the freedom to pursue larger questions within the biomedical and chemical sciences, questions that are for the most part conceptually driven," said MacMicking. The Searle award will bring new rese
'"/>

Contact: Janet Rettig Emanuel
janet.emanuel@yale.edu
203-432-2157
Yale University
17-May-2005


Page: 1 2

Related biology news :

1. NWO/Spinoza Prize for psychologist, immunologist, biologist and physicist
2. UVa researcher studying disease that cripples newborns
3. Stem cells provide new tool for studying disease and identifying ALS drugs
4. Sandia researchers take new approach to studying how cells respond to pathogens
5. Researchers make progress in studying genetic traits of India-born populations
6. Disappearing nest egg: Researcher studying declining numbers of macaws
7. Berkeley lab life scientists are leaders in team to detect cancer by studying proteins in the blood
8. Breakthrough offers new tool for studying degenerative disease
9. OHSU studying drug for bone-deforming disorder
10. New tools developed for studying neurodegenerative brain disorders
11. NYUS Childress demonstrates tool for studying hovering flight at international science meeting

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... , ... July 01, 2020 , ... ... its phase 1a findings of Neihulizumab, a biologic for the treatment of steroid-refractory ... 2020. Led by hemato-oncologist Dr. Paul J Martin of the Fred Hutchinson Cancer ...
(Date:7/1/2020)... ... July 01, 2020 , ... Cure Glioblastoma, a registered 501(c)(3) ... and aggressive adult brain cancer—announced today the appointments of its first Senior Fellows: ... supporting the organization’s initiatives and overall vision. , "Senior Fellows are more than ...
(Date:6/25/2020)... , ... June 24, 2020 , ... ... enterprise software and software-driven clinical data services that accelerate drug development, is collaborating ... selinexor, an XPO1 inhibitor, in hospitalized patients with severe COVID-19. This is the ...
Breaking Biology News(10 mins):
(Date:6/28/2020)... ... June 25, 2020 , ... With ... a vaccine or drug treatment. In an effort to better understand the cellular ... the world’s largest imaging dataset portraying therapeutic compound effects from over 1,600 approved ...
(Date:6/23/2020)... ... June 23, 2020 , ... DeCurtis Corporation, ... announced today that Derek Fournier has been appointed CEO and President. Founder and ... effective immediately. , “DeCurtis Corporation has been on an incredible journey for ...
(Date:6/19/2020)... ... June 18, 2020 , ... The Vitaspace project was founded ... forces to radically prolong life and find a way (medicine or technology) that will ... was supported by various scientists from all over the world, doctors, and all people ...
(Date:6/11/2020)... ... June 09, 2020 , ... Reducing carbon emissions has ... From the Paris Agreement to stock market dips, ways to reduce CO2 is something ... to their portfolio. Most of the biofuels being produced today are created from recycled ...
Breaking Biology Technology:
Cached News: